Mirum Pharmaceuticals, Inc. (MIRM) Free cash flow 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$54.9MFY2025 · since FY2019: -$39.6M → $54.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.9M | +488.0% |
| FY2024 | $9.3M | +113.1% |
| FY2023 | -$71.1M | +41.0% |
| FY2022 | -$120.4M | +9.3% |
| FY2021 | -$132.8M | -48.7% |
| FY2020 | -$89.3M | -125.3% |
| FY2019 | -$39.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating marginMIRM Operating cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →